Xylem (XYL) Revenue (2016 - 2026)

Xylem has reported Revenue over the past 17 years, most recently at $2.1 billion for Q1 2026.

For Q1 2026, Revenue rose 2.71% year-over-year to $2.1 billion; the TTM value through Mar 2026 reached $9.1 billion, up 5.73%, while the annual FY2025 figure was $9.0 billion, 5.52% up from the prior year.
Revenue for Q1 2026 was $2.1 billion at Xylem, down from $2.4 billion in the prior quarter.
Over five years, Revenue peaked at $2.4 billion in Q4 2025 and troughed at $1.3 billion in Q1 2022.
A 5-year average of $1.9 billion and a median of $2.1 billion in 2023 define the central range for Revenue.
Biggest five-year swings in Revenue: grew 0.96% in 2022 and later soared 50.43% in 2023.
Year by year, Revenue stood at $1.5 billion in 2022, then soared by 40.64% to $2.1 billion in 2023, then grew by 6.52% to $2.3 billion in 2024, then increased by 6.25% to $2.4 billion in 2025, then fell by 11.35% to $2.1 billion in 2026.
Business Quant data shows Revenue for XYL at $2.1 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.3 billion in Q3 2025.

Peer Comparison